ZEB1 and gastric cancer: Tiffon et al. demonstrated that in the SRCC GC cell line MKN45 and poorly differentiated GC patient-derived xenograft cells, TAZ is overexpressed and overactivated, controlling the expression of TAZ-TEAD target genes, including CYR61 and AXL among others, and of the EMT main transcription factor ZEB1, which decrease in TAZ KD cells.